MOSCOW – Russia’s sovereign wealth fund said on Wednesday it agreed to supply 25 million doses of its potential COVID-19 vaccine to Egypt Pharco, which it has described as one of the country’s leading pharmaceutical groups.
The Russian Direct Investment Fund has concluded several agreements to obtain the Sputnik V vaccine abroad, adding one hundred million doses in India, where it also plans to conduct clinical trials (report via Maria Kannedova; written through Alexander Marrow; edited through Andrew Heavens).
Sign up for news from the National Post, a department of Postmedia Network Inc.
An error has occurred, please provide a valid email address.
A welcome email is on its way. If you don’t see it, check your unwanted folder.
The next factor in the newsletter will soon be in your inbox.
We found a challenge when you signed up. Check again
Postmedia is committed to maintaining a still civil discussion forum and encouraging all readers to express their views on our articles. Comments can take up to an hour to moderate before appearing on the site. We ask that you keep your comments applicable and respectful. I’ve enabled email notifications. You will now receive an email if you get a reaction to your comment, an update to a comment thread that follows, or if a user follows it. Check out our network regulations for more data and main points on how to adjust your email settings.
365 Bloor Street East, Toronto, Ontario, M4W 3L4
© 2020 National Post, a department of Postmedia Network Inc. All rights reserved. Unauthorized broadcasting, transmission or transmission is strictly prohibited.
This uses cookies to personalize your content (including ads) and allows us to analyze our traffic. Learn more about cookies here. By using our site, you agree to our terms of use and privacy policy.